supplementary figure s1
DESCRIPTION
Supplementary figure S1. Supplementary figure S2. A. B. DNA replication %. DNA replication %. NU. EB+NU. EB. ctl. 20’ 60’. 20’ 60’. 20’ 60’. 20’ 60’. cdc45. RPA. PCNA. MCM3. Supplementary figure S3. A. B. DNA replication %. Supplementary figure S4. % DNA replicated. - PowerPoint PPT PresentationTRANSCRIPT
0
20
40
60
80
100
120
0 20 40 60 80 100 120
concentration (µM)
% f
luo
resc
ence ethidium
Fascaplycin
Cisplatin
Oxaliplatin
Echinomycin
Doxorubicin
Supplementary figure S1.
0102030405060708090100
time (min)
0
10
20
30
40
50
60
70
80
90
time (min)
A B
Supplementary figure S2.
DN
A r
ep
lic
ati
on
%
DN
A r
ep
lic
ati
on
%
20 40 60 90 120EB 25µM + NU 100µMNU 100µMEB 25µM
ctl
0
10
20
30
40
50
60
Time (min)
Supplementary figure S3.
cdc45
RPA
PCNA
MCM3
ctl EB NU EB+NU20’ 60’ 20’ 60’ 20’ 60’ 20’ 60’
A
B
DN
A r
ep
lic
ati
on
%
Supplementary figure S4.
0 25 45 60 90 1200
20
40
60
80
100
120
time (min)
Cisplatin
Oxaliplatin
Fascaplycin
DMSO
% DNA replicated
Supplementary figure S5.
2040
6090
1200
20
40
60
80
100
DN
A r
ep
lic
ati
on
%
Supplementary figure S6.
℗-MCM2
- 5 20 60
Cdc45
RPA
MCM7
Supplementary figure S7.
Ctl 90’ EB 90’ 30’
DNA
DHCC
Supplementary figure S8.
DNA
Lamin B3
CTL10min 10min 45min45min
EB 50µM